scholarly article | Q13442814 |
P50 | author | Philip F Halloran | Q40000948 |
P2093 | author name string | Anette Melk | |
Adis Tasanarong | |||
Attapong Vongwiwatana | |||
David C Rayner | |||
P2860 | cites work | The natural history of chronic allograft nephropathy | Q44688416 |
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro | Q28579283 | ||
Renal fibrosis: an update | Q34244748 | ||
Post-transplant renal tubulitis: the recruitment, differentiation and persistence of intra-epithelial T cells. | Q35030793 | ||
Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells | Q35032352 | ||
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention | Q35615604 | ||
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis | Q35746891 | ||
Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation | Q35746896 | ||
Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition | Q40595085 | ||
Protein S100A4: too long overlooked by pathologists? | Q41867135 | ||
Chronic allograft nephropathy--biopsy findings and outcome | Q43815860 | ||
Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies | Q44039616 | ||
Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts | Q44048416 | ||
Risk factors for late kidney allograft failure | Q44173388 | ||
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury | Q44479221 | ||
The stability of the glomerular filtration rate after renal transplantation is improving | Q44560815 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1367-1374 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | American Journal of Transplantation | Q4744273 |
P1476 | title | Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis | |
P478 | volume | 5 |
Q41270698 | A choroid plexus cyst in the fourth ventricle of a Sprague-Dawley rat. |
Q53605893 | A critical look at growth factors and epithelial-to-mesenchymal transition in the adult kidney. Interrelationships between growth factors that regulate EMT in the adult kidney. |
Q42650338 | A novel model of surgical injury in adult rat kidney: a "pouch model". |
Q28588516 | A proximal activator of transcription in epithelial-mesenchymal transition |
Q34570605 | Analysis of machine perfusion benefits in kidney grafts: a preclinical study |
Q42849659 | Analysis of urinary gene expression of epithelial-mesenchymal transition markers in kidney transplant recipients. |
Q33593163 | Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model |
Q38402144 | Association Studies of Bone Morphogenetic Protein 2 Gene Polymorphisms With Acute Rejection in Kidney Transplantation Recipients |
Q80060245 | Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis |
Q94521575 | Blocking thrombospondin-1 signaling via CD47 mitigates renal interstitial fibrosis |
Q35244151 | Cardiac allograft vasculopathy: a donor or recipient induced pathology? |
Q36582300 | Chronic allograft nephropathy in paediatric renal transplantation |
Q84238174 | Chronic rejection of human kidney allografts |
Q38076666 | Clinical and histological predictors of long-term kidney graft survival. |
Q36857821 | Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling |
Q37813412 | Consequences of transplant quality on chronic allograft nephropathy |
Q37811517 | Contribution of epithelial plasticity to renal transplantation-associated fibrosis |
Q39801458 | Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. |
Q43890254 | Distribution and expression of fibroblast-specific protein chemokine CCL21 and chemokine receptor CCR7 in renal allografts |
Q38316792 | Diverse origins of the myofibroblast—implications for kidney fibrosis |
Q37248336 | EMT and proteinuria as progression factors |
Q36796755 | Early epithelial phenotypic changes predict graft fibrosis |
Q28583621 | Epithelial to mesenchymal transformation in tubular epithelial cells undergoing anoxia |
Q34817706 | Epithelial to mesenchymal transition as a biomarker in renal fibrosis: are we ready for the bedside? |
Q92831688 | Epithelial to mesenchymal transition in endomyocardial biopsies from orthotopic heart transplant recipients |
Q80800796 | Epithelial-mesenchymal transition (EMT) of renal tubular cells in canine glomerulonephritis |
Q84605086 | Epithelial-mesenchymal transition in kidney grafts |
Q28083351 | Epithelial-mesenchymal transition: An emerging target in tissue fibrosis |
Q33935337 | Epithelial-mesenchymal transitions of bile duct epithelial cells in primary hepatolithiasis |
Q37218081 | Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis |
Q36796745 | Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage |
Q64235401 | Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress |
Q37498285 | Fibroblast activation and myofibroblast generation in obstructive nephropathy |
Q35081077 | Gender difference and sex hormone production in rodent renal ischemia reperfusion injury and repair. |
Q37813407 | Genomics of chronic allograft injury |
Q36842403 | Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis |
Q50472142 | Histopathology and biomarkers in prediction of renal function in children after kidney transplantation. |
Q43092586 | Hypoxia Induces Mesenchymal Gene Expression in Renal Tubular Epithelial Cells: An in vitro Model of Kidney Transplant Fibrosis |
Q42740954 | Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal |
Q37668231 | Inflammation and EMT: an alliance towards organ fibrosis and cancer progression |
Q46369064 | Inhibition of connective tissue growth factor by small interfering RNA prevents renal fibrosis in rats undergoing chronic allograft nephropathy |
Q42574585 | Lack of α8 integrin leads to morphological changes in renal mesangial cells, but not in vascular smooth muscle cells. |
Q35153318 | Late kidney allograft loss: what we know about it, and what we can do about it |
Q37264359 | Low-dose carbon monoxide inhibits progressive chronic allograft nephropathy and restores renal allograft function. |
Q52585581 | Mesenchymal transition in kidney collecting duct epithelial cells. |
Q35185566 | MicroRNA-328 inhibits renal tubular cell epithelial-to-mesenchymal transition by targeting the CD44 in pressure-induced renal fibrosis |
Q37724869 | Molecular pathways involved in loss of graft function in kidney transplant recipients. |
Q34322260 | Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy |
Q36010095 | New insights into epithelial-mesenchymal transition in kidney fibrosis |
Q36802004 | Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts |
Q46215951 | Progression of pulse pressure in kidney recipients durably exposed to CsA is a risk factor for epithelial phenotypic changes: an ancillary study of the CONCEPT trial. |
Q41280800 | Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo |
Q37301840 | Recent developments in kidney transplantation--a critical assessment |
Q86406125 | Reduction of osteopontin in vivo inhibits tubular epithelial to mesenchymal transition in rats with chronic allograft nephropathy |
Q46132415 | Relation of urinary gene expression of epithelial-mesenchymal transition markers with initial events and 1-year kidney graft function |
Q37568489 | Renal studies provide an insight into cardiac extracellular matrix remodeling during health and disease |
Q47398993 | S100A4 amplifies TGF-β-induced epithelial-mesenchymal transition in a pleural mesothelial cell line |
Q57124983 | S100A4 expression is increased in stricture fibroblasts from patients with fibrostenosing Crohn's disease and promotes intestinal fibroblast migration |
Q37103177 | S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? |
Q37856705 | Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition |
Q35683125 | Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells |
Q55709245 | Simultaneous activation of innate and adaptive immunity participates in the development of renal injury in a model of heavy proteinuria. |
Q34548148 | Smad mediated regulation of inhibitor of DNA binding 2 and its role in phenotypic maintenance of human renal proximal tubule epithelial cells |
Q28505069 | Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney |
Q38866153 | Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. |
Q54576090 | Suppressors of cytokine signaling inhibit tubular epithelial cell-myofibroblast transdifferentiation. |
Q29616456 | TGF-beta and epithelial-to-mesenchymal transitions |
Q37113958 | TGF-beta mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease |
Q39407129 | The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease |
Q50458666 | The role of macrophages in the development of human renal allograft fibrosis in the first year after transplantation. |
Q36447581 | Therapeutic targets in the treatment of allograft fibrosis |
Q51904875 | Transcriptome analysis reveals heterogeneity in the injury response of kidney transplants. |
Q39413604 | Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation |
Q33251846 | Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B. |
Q42974107 | Urinary connective tissue growth factor is a biomarker in a rat model of chronic nephropathy |
Q54355169 | Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy. |
Q52983786 | Use of Contrast-Enhanced Ultrasonography to Evaluate Chronic Allograft Nephropathy in Rats and Correlations between Time-Intensity Curve Parameters and Allograft Fibrosis. |
Q42795565 | Vimentin expression and myofibroblast infiltration are early markers of renal dysfunction in kidney transplantation: an early stage of chronic allograft dysfunction? |
Q52720613 | Vimentin expression is required for the development of EMT-related renal fibrosis following Unilateral Ureteral Obstruction in mice. |
Q81784340 | [Epithelial-mesenchymal transition of the renal graft] |
Q53624421 | [The epithelial-mesenchymal transition and fibrosis of the renal transplant]. |
Search more.